Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities.
Mazie TsangThomas William LeBlancPublished in: JCO oncology practice (2024)
@JCOOP_ASCO editorial on unique needs of end-of-life care for different blood cancers discusses: #pallheme improves QOL but less utilized in cancers. Contextualize Weisse et al study. More #pallheme research needed for lymphoma and myeloma in era of cell therapy.